| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |